Close Menu

NEW YORK (GenomeWeb) – Pangea Laboratory said yesterday that it has licensed a urine-based laboratory-developed test for bladder cancer detection from Zymo Research.

Commercialized and sold under the name Bladder Care, the test uses qPCR to measure the methylation level of three bladder cancer-specific biomarkers in patient urine samples that can be collected at home or in a physician's office.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.